Efficacy of interleukin-10 gene electrotransfer into skeletal muscle in mice with collagen-induced arthritis

Journal of Gene Medicine

Volumn 5, Issue 2, 2003, Pages 164-171

  Saidenberg Kermanac'h, Nathalie ^a   Bessis, Natacha ^a   Deleuze, Virginie ^b   Bloquel, Carole ^a   Bureau, Michel ^b   Scherman, Daniel ^b   Boissier, Marie Christophe ^a  

^a UNIVERSITÉ PARIS 13   (France)

^b SANOFI   (France)

Author keywords

Collagen induced arthritis; Electrotransfer; Inflammation; Interleukin 10; Naked DNA; Rheumatoid arthritis

Indexed keywords

COLLAGEN TYPE 2; INTERLEUKIN 10; PLASMID DNA; SODIUM CHLORIDE; VIRUS VECTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS; DISEASE SEVERITY; DRUG EFFICACY; GENE TRANSFER; IMMUNIZATION; IN VIVO STUDY; LOW DRUG DOSE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SKELETAL MUSCLE; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY; ANIMAL; ARTHRITIS; CYTOLOGY; DBA MOUSE; ELECTROCHEMISTRY; GENE THERAPY; GENETICS; HUMAN; IMMUNOLOGY; KNEE; METABOLISM; PATHOLOGY; PHYSIOLOGY; PLASMID;

ANIMALS; ARTHRITIS, EXPERIMENTAL; ELECTROCHEMISTRY; GENE THERAPY; GENE TRANSFER TECHNIQUES; HUMANS; INTERLEUKIN-10; KNEE JOINT; MALE; MICE; MICE, INBRED DBA; MUSCLE, SKELETAL; PLASMIDS;

EID: 0037791929     PISSN: 1099498X     EISSN: None     Source Type: Journal    
DOI: 10.1002/jgm.321     Document Type: Article

References (41)

1. Pisetsky DS. Tumor necrosis factor blockers in rheumatoid arthritis. N Engl J Med 2000; 342: 810-811.
2. Katsikis PD, Chu CQ, Brennan FM, Maini RN, Feldman M. Immunoregulatory role of interleukin-10 in rheumatoid arthritis. J Exp Med 1994; 179: 1517-1527.
3. De Waal Malefyt R. IL-10. In Cytokine Reference, vol 1. Oppenheim JJ, Feldmann M (eds). Academic Press: London, 2000; 165.
4. Tanaka Y, Otsuka T, Hotokebuchi T, et al. Effect of IL-10 on collagen-induced arthritis in mice. Inflamm Res 1996; 45: 283-288.
5. Walmsley M, Katsikis PD, Abney E, et al. Interleukin-10 inhibition of the progression of established collagen-induced arthritis. Arthritis Rheum 1996; 39: 495-503.
6. Persson S, Mikulowska A, Narula, O'Garra A, Molmdahl R. Interleukin-10 suppresses the development of collagen-induced arthritis and ameliorates sustained arthritis in rats. Scand J Immunol 1996; 44: 607-614.
7. Miyata M, Sasajima T, Sato H, et al. Suppression of collagen-induced arthritis in mice utilizing plasmid DNA encoding interleukin 10.2 J Rheumatol 2000; 27: 1601-1605.
8. Fellowes R, Etheridge CJ, Coade S, et al. Amelioration of established collagen-induced arthritis by systemic IL-10 gene delivery. Gene Ther 2000; 7: 967-977.
9. Neumann E, Schaefer-Ridder M, Wang Y, Hofschneider PH. Gene transfer into mouse lyoma cells by electroporation in high electric fields. EMBO J 1982; 1: 841-845.
10. Potter H. Electroporation in biology: methods, applications, and instrumentation. Anal Biochem 1988; 174: 361-373.
11. Mir LM, Bureau MF, Rangara R, Schwartz B, Scherman D. Long-term, high level in vivo gene expression after electric pulse-mediated gene transfer into skeletal muscle. C R Acad Sci III 1998; 321: 893-899.
12. Mir L, Bureau MF, Gehl J, et al. High-efficiency gene transfer into skeletal muscle mediated by electric pulse. Proc Nat Acad Sci 1999; 96: 4262-4267.
13. Aihara H, Miyazaki JI. Gene transfer into muscle by electroporation in vivo. Nat Biotechnol 1998; 16: 867-870.
14. Kreiss P, Bettan M, Crouzet J, Scherman D. Erythropoietin secretion and physiological effect in mouse after intramuscular plasmid DNA electrotransfer. J Gene Med 1999; 1: 245-250.
15. Bettan M, Emmanuel F, Darteil R, et al. High level protein secretion into blood circulation after electric pulse-mediated gene transfer into skeletal muscle. Mol. Ther 2000; 2: 204-210.
16. Rizutto G, Cappelletti M, Maione D, et al. Efficient and regulated erythropoietin production by naked DNA injection and muscle electroporation. Proc Natl Acad Sci 1999; 96: 6417-6422.
17. Mallat Z, Besnard S, Duriez M, et al. Protective role of interleukin-10 in atherosclerosis. Circ Res 1999; 85: e17-e24.
18. Payen E, Bettan M, Rouyer-Fessard P, Beuzard Y, Scherman D. Improvement of mouse beta-thalassemia by electrotransfer of erythropoeitin cDNA. Exp Hematol 2001; 29: 295-300.
19. Nakamura H, Isaka Y, Tsujie M, et al. Electroporation-mediated PDGF receptor-IgG chimera gene transfer ameliorates experimental glomerulonephritis. Kidney Int 2001; 59 2134-2145.
20. Nakano A, Matsumori A, Kawamoto S, et al. Cytokine gene therapy for myocarditis by in vivo electroporation. Hum Gene Ther 2001; 12: 1289-1297.
21. Hanna E, Zhang X, Woodlis J, Breau R, Suen J, Li S. Intramuscular electroporation delivery of IL-12 gene for treatment of squamous cell carcinoma located at a distant site. Cancer Gene Ther 2001; 8: 151-157.
22. Li S, Zhang X, Xia X, et al. Intramuscular electroporation delivery of IFN-a gene therapy for inhibition of tumor growth located at a distant site. Gene Ther 2001; 8: 400-407.
23. Yin D, Tang JG. Gene therapy for streptozotocin-induced diabetic mice by electroporational transfer of naked human insulin precursor DNA into skeletal muscle in vivo. FEBS Lett 2001; 495 16-20.
24. Bachy L, Boudet F, Bureau M, et al. Electric pulses increase the immunogenicity of an influenza DNA vaccine injected intramuscularly in the mouse. Vaccines 2001; 19: 1688-1693.
25. Soubrier F, Cameron B, Manse B, et al. PCOR: a new design of plasmid vectors for nonviral gene therapy. Gene Ther 1999; 6: 1482-1488.
26. Ausubel FM, et al. In Current Protocols in Molecular Biology, Ausubel FM, et al. (eds). John Wiley: New York, 1994; 1.7.6-1.7.8.
27. Boissier MC, Chiocchia G, Ronziere MC, Herbage D, Fournier C. Arthritogenicity of minor cartilage collagens (type IX and type XI) in mice. Arthritis Rheum 1990; 33: 1-8.
28. Boissier MC, Feng XZ, Carlioz A, Roudier R, Fournier C. Experimental auto-immune arthritis in mice. Homologous type II collagen is responsible for self-perpetuating chronic polyarthritis. Ann Rheum Dis 1987; 46: 691-700.
29. Manoury-Schwartz B, Chiocchia G, Bessis N, et al. High susceptibility to collagen-induced arthritis in mice lacking IFN-gamma receptors. J Immunol 1997; 158: 5501-5506.
30. Silvestre JB, Mallat Z, Duriez M, et al. Antiangiogenic effect of interleukin-10 in ischemia-induced angiogenesis in mice hindlimb. Circ Res 2000; 87: 448-452.
31. Al-Janadi M, Al-Dalaan A, Al-Balla S, Al-Humaidi M, Raziuddin S. Interleukin-10 (IL-10) secretion in systemic lupus erythematosus and rheumatoid arthritis: IL-10 dependent CD4+CD45RO+ T cell-B cell antibody synthesis. J Clin Immunol 1996; 16: 198-207.
32. Joosten LA, Lubberts E, Durez P, et al. Role of interleukin-4 and interleukin-10 in murine collagen-induced arthritis. Protective effect of interleukin-4 and interleukin-10 treatment on cartilage destruction. Arthritis Rheum 1997; 40: 249-260.
33. Apparailly F, Verwaerde C, Jacquet C, Auriault C, Sany J, Jorgensen C. Adenovirus-mediated transfer of viral IL-10 gene inhibits murine collagen-induced arthritis. J Immunol 1998; 160: 5213-5220.
34. Whalen JD, Lechman EL, Carlos CA, et al. Adenoviral transfer of the viral IL-10 gene periarticularly to mouse paws suppresses development of collagen-induced arthritis in both injected and uninjected paws. J Immunol 1999; 162: 3625-3632.
35. Ma Y, Thornton S, Duwel LE, et al. Inhibition of collagen-induced arthritis in mice by viral IL-10 gene transfer. J Immunol 1998; 161: 1516-1524.
36. Quattrocchi E, Dallman MJ, Dhillon AP, Quaglia A, Bagnato G, Feldman M. Murine IL-10 gene transfer inhibits established collagen-induced arthritis and reduces adenovirus-mediated inflammatory responses in mouse liver. J Immunol 2001; 166: 5970-5978.
37. Jorgensen C, Apparailly F, Canovas F, et al. Systemic viral interleukin-10 gene delivery prevents cartilage invasion by human rheumatoid synovial tissue engrafted in SCID mice. Arthritis Rheum 1999; 42: 678-685.
38. Lechman ER, Jaffurs D, Ghivizzani SC, et al. Direct adenoviral gene transfer of viral IL-10 to rabbit knees with experimental arthritis ameliorates disease in both injected and controlateral knees. J Immunol 1999; 163: 2202-2208.
39. Bessis N, Boissier MC, Ferrara P, Blankenstein T, Fradelizi D, Fournier C. Attenuation of collagen-induced arthritis in mice by treatment with vector cells engineered to secrete interleukin-13. Eur J Immunol 1996; 26: 2399-2403
40. Bessis N, Honiger J, Damotte D, et al. Encapsulation in hollow fibres of xenogeneic cells engineered to secrete IL-4 or IL-13 ameliorates murine collagen-induced arthritis. Eur J Immunol 1999; 27: 1451-1458.
41. Horsfall AC, Butler DM, Marinova L, et al. Suppression of collagen-induced arthritis by continuous administration of IL-4. J Immunol 1997; 159: 5687-5696.